Article
Genetic susceptibility to thalidomide embryopathy in humans: Study of candidate development genes.
Birth defects research - 15 Mar 2018
Gomes Julia do Amaral, Kowalski Thayne Woycinck, Fraga Lucas Rosa, Tovo-Rodrigues Luciana, Sanseverino Maria Teresa Vieira, Schuler-Faccini Lavínia, Vianna Fernanda Sales Luiz
Abstract excerpt
Thalidomide is a drug used worldwide for several indications, but the molecular mechanisms of its teratogenic property are not fully understood. Studies in animal models suggest the oxidative stress, the inhibition of angiogenesis, and the binding to E3-ubiquitin ligase complex as mechanisms by which thalidomide can change the expression of genes important to embryonic development. In this study, seven...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
